Infection | Drug | Adult dosage | Pediatric dosage |
Hydatid cyst, see TAPEWORM infection |
Hymenolepis nana, see TAPEWORM infection |
ISOSPORIASIS (Isospora belli) |
Drug of choice:48 | Trimethoprim-sulfamethoxazole7 | TMP 160 mg/SMX 800 mg (1 DS tab) PO bid X 10d | TMP 10 mg/kg/d/SMX 50 mg/kg/d PO in 2 doses X 10d |
LEISHMANIA |
Visceral49,50 |
Drug of choice: | Liposomal amphotericin B51 | 3 mg/kg/d IV d 15, 14 and 2152 | 3 mg/kg/d IV d 15, 14 and 2152 |
OR | Sodium stibogluconate* | 20 mg Sb/kg/d IV or IM X 28d | 20 mg Sb/kg/d IV or IM X 28d |
OR | Miltefosine53* | 2.5 mg/kg/d PO (max 150 mg/d) X 28d | 2.5 mg/kg/d PO (max 150 mg/d) X 28d |
Alternative: | Meglumine antimonate* | 20 mg Sb/kg/d IV or IM X 28d | 20 mg Sb/kg/d IV or IM X 28d |
OR | Amphotericin B7 | 1 mg/kg IV daily x 1520d or every second day for up to 8 wks | 1 mg/kg IV daily X 1520d or every second day for up to 8 wks |
OR | Paromomycin7,13,54* | 15 mg/kg/d IM X 21d | 15 mg/kd/d IM X 21d |
Cutaneous49,55 |
Drugs of choice: | Sodium stibogluconate* | 20 mg Sb/kg/d IV or IM X 20d | 20 mg Sb/kg/d IV or IM X 20d |
OR | Meglumine antimonate* | 20 mg Sb/kg/d IV or IM X 20d | 20 mg Sb/kg/d IV or IM X 20d |
OR | Miltefosine53* | 2.5 mg/kg/d PO (max 150 mg/d) X 28d | 2.5 mg/kg/d PO (max 150 mg/d) X 28d |
Alternative:56 | Paromomycin7,13,54* | Topically 2x/d X 10-20d | Topically 2x/d X 10-20d |
OR | Pentamidine7 | 2-3 mg/kg IV or IM daily or every second day X 47 doses57 | 23 mg/kg IV or IM daily or every second day X 47 doses57 |
Mucosal49,58 |
Drug of choice: | Sodium stibogluconate* | 20 mg Sb/kg/d IV or IM X 28d | 20 mg Sb/kg/d IV or IM X 28d |
OR | Meglumine antimonate* | 20 mg Sb/kg/d IV or IM X 28d | 20 mg Sb/kg/d IV or IM X 28d |
OR | Amphotericin B7 | 0.51 mg/kg IV daily or every second day for up to 8wks | 0.51 mg/kg IV daily or every second day for up to 8wks |
OR | Miltefosine53* | 2.5 mg/kg/d PO (max 150 mg/d) X 28d | 2.5 mg/kg/d PO (max 150 mg/d) X 28d |
LICE infestation (Pediculus humanus, P. capitis, Phthirus pubis)59 |
Drug of choice: | 0.5% Malathion60 | Topically | Topically |
OR | 1% Permethrin61 | Topically | Topically |
Alternative: | Pyrethrins with piperonyl butoxide60 | Topically | Topically |
OR | Ivermectin7,16,62 | 200 mcg/kg PO | >15kg: 200 mcg/kg PO |
Loa loa, see FILARIASIS | | | |
MALARIA, Treatment of (Plasmodium falciparum,63P. vivax,64P. ovale, and P. malariae65) |
ORAL66 |
P. falciparum or unidentified species acquired in areas of chloroquine-resistant P. falciparum63 |
Drug of choice:67
| Atovaquone/proguanil68 | 2 adult tabs bid69 or 4 adult tabs once/d X 3d | < 5kg: not indicated 58kg: 2 peds tabs once/d X 3d 910kg: 3 peds tabs once/d X 3d 1120kg: 1 adult tab once/d X 3d 2130kg: 2 adult tabs once/d X 3d 3140kg: 3 adult tabs once/d X 3d >40kg: 4 adult tabs once/d X 3d |
OR | Quinine sulfate | 650 mg q8h X 3 or 7d70 | 30 mg/kg/d in 3 doses X 3 or 7d70 |
plus | | |
doxycycline7,21,71 | 100 mg bid X 7d | 4 mg/kg/d in 2 doses X 7d |
or plus | | |
tetracycline7,21 | 250 mg qid X 7d | 25 mg/kg/d in 4 doses X 7d |
or plus | | |
clindamycin7,18,72 | 20 mg/kg/d in 3 doses X 7d73 | 20 mg/kg/d in 3 doses X 7d |
Alternative:67
| Mefloquine74,75 | 750 mg followed 12 hrs later by 500 mg | 15 mg/kg followed 12 hrs later by 10 mg/kg |
OR | Artemether/lumefantrine76,77* | 6 doses over 3d (4 tabs/dose at 0, 8, 24, 36, 48 and 60 hours) | 6 doses over 3d at same intervals as adults; < 15kg: 1 tab/dose 1525kg: 2 tabs/dose 2535kg: 3 tabs/dose >35kg: 4 tabs/dose |
OR | Artesunate76*
plus see footnote 78 | 4 mg/kg/d X 3d | 4 mg/kg/d X 3d |
P. vivax acquired in areas of chloroquine-resistant P. vivax64 |
Drug of choice:67
| Mefloquine74 | 750 mg PO followed 12 hrs later by 500 mg | 15 mg/kg PO followed 12 hrs later by 10 mg/kg |
OR | Atovaquone/proguanil68 | 2 adult tabs bid69 or 4 adult tabs once/d X 3d | < 5kg: not indicated 58kg: 2 peds tabs once/d X 3d 910kg: 3 peds tabs once/d X 3d 1120kg: 1 adult tab once/d X 3d 2130kg: 2 adult tabs once/d X 3d 3140kg: 3 adult tabs once/d X 3d >40kg: 4 adult tabs once/d X 3d |
either followed by |
primaquine phosphate79 | 30 mg base/d PO X 14d | 0.6 mg/kg/d PO X 14d |
Alternative:67 79 | Chloroquine phosphate80 | 25 mg base/kg PO in 3 doses over 48 hrs81 | 25 mg base/kg PO in 3 doses over 48 hrs81 |
OR | Quinine sulfate | 650 mg PO q8h X 3-7d70 | 30 mg/kg/d PO in 3 doses X 3-7d70 |
plus |
doxycycline7,21,71 | 100 mg PO bid X 7d | 4 mg/kg/d PO in 2 doses X 7d |
either followed by |
primaquine | 30 mg base/d PO X 14d | 0.6 mg/kg/d PO X 14d phosphate79 |
All Plasmodium species except chloroquine-resistant P. falciparum63 and chloroquine-resistant P. vivax64 |
Drug of choice:67 79 | Chloroquine phosphate80 | 1 g (600 mg base) PO, then 500 mg(300 mg base) 6 hrs later, then 500mg (300 mg base) at 24 and 48 hrs81 | 10 mg base/kg (max. 600 mg base) PO, then 5 mg base/kg 6 hrs later, then 5 mg base/kg at 24 and 48 hrs81 |
PARENTERAL66 |
All Plasmodium species (Chloroquine-sensitive and resistant) |
Drug of choice:67 79,82 | Quinidine gluconate83 | 10 mg/kg IV loading dose (max. 600 mg) in normal saline over 12 hrs, followed by continuous infusion of 0.02 mg/kg/min until PO therapy can be started | 10 mg/kg lV loading dose (max. 600 mg) in normal saline over 12 hrs, followed by continuous infusion of 0.02 mg/kg/min until PO therapy can be started |
OR | Quinine dihydrochloride83* | 20 mg/kg IV loading dose in 5% dextrose over 4 hrs, followed by 10 mg/kg over 24 hrs q8h (max. 1800 mg/d) until PO therapy can be started | 20 mg/kg IV loading dose in 5% dextrose over 4 hrs, followed by 10 mg/kg over 24 hrs q8h (max. 1800 mg/d) until PO therapy can be started |
OR | Artesunate76* plus see footnote 78 | 2.4 mg/kg/dose IV X 3d at 0, 12, 24, and 48 hrs | 2.4 mg/kg/dose IV X 3d at 0, 12, 24, and 48 hrs |
Malaria, Prevention of84 |
All Plasmodium species in chloroquine-sensitive areas63,64,65 |
Drug of choice:67,79,85 | Chloroquine phosphate80,86 | 500 mg (300 mg base) PO once/wk87 | 5 mg/kg base PO once/wk, up to adult dose of 300 mg base87 |